We are live on ! Find out more
APGNW

Apexigen, Inc. WarrantApexigen, Inc. Warrant

Delisted

APGNW was delisted on the 22nd of August, 2023.

11 hedge funds and large institutions have $890K invested in Apexigen, Inc. WarrantApexigen, Inc. Warrant in 2021 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 1111 (0)

0% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 3

31% less capital invested

Capital invested by funds: $1.29M → $890K (-$404K)

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2

Holders
11
Holders Change
Holders Change %
0%
% of All Funds
0.19%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
1
Reduced
2
Closed
3
Calls
$66K
Puts
Net Calls
+$66K
Net Calls Change
-$86K

APGNW Hedge Fund Activity: Q3 2021 in Review

11 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in Apexigen, Inc. WarrantApexigen, Inc. Warrant (APGNW) for Q3 2021, worth a combined $890K — down 31% from $1.29M a quarter earlier.

Fund positioning in APGNW was balanced in Q3 2021: 3 funds opened new positions, 3 closed out, 1 added to existing stakes and 2 trimmed.

The largest buyer was K2 Principal Fund, opening a new position worth an estimated $123K. The largest seller was Fir Tree Capital Management, exiting entirely with an estimated $171K sold.

  • 11 institutional investors held Apexigen, Inc. WarrantApexigen, Inc. Warrant (APGNW) as of Q3 2021, unchanged from Q2 2021.
  • Funds reported $890K of Apexigen, Inc. WarrantApexigen, Inc. Warrant stock for Q3 2021, down 31% quarter-over-quarter.
  • 3 funds opened new Apexigen, Inc. WarrantApexigen, Inc. Warrant positions in Q3 2021 and 3 closed out, a net change of 0 holders.
  • The largest Apexigen, Inc. WarrantApexigen, Inc. Warrant buyer in Q3 2021 was K2 Principal Fund, an estimated $123K added.
  • The largest Apexigen, Inc. WarrantApexigen, Inc. Warrant seller in Q3 2021 was Fir Tree Capital Management, an estimated $171K sold.

Based on aggregated 13F filings for Q3 2021.